カテゴリー： QYResearch, 世界, 医療/バイオ

エピルビシン塩酸塩注射液のグローバル市場2023年：5mg、10mg

◆英語タイトル：Global Epirubicin Hydrochloride Injection Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8753）◆商品コード：QYR23MA8753
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のエピルビシン塩酸塩注射液市場について調査・分析し、世界のエピルビシン塩酸塩注射液市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（5mg、10mg）、用途別セグメント分析（白血病、悪性リンパ腫、多発性骨髄腫、乳がん、肺がん、軟部肉腫、胃がん、大腸がん、卵巣がん、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Akorn、Aurobindo Pharma、Cipla、Ebewe Pharma、Fresenius Kabi Usa、Impax Laboratories、Mylan Laboratories、Nippon Kayaku、Pfizer、Sawai Pharmaceutical、Zennova、Beijing Union Pharmaceutical Factory、Hisun Pharmaceutical、Hanhui Pharmaceutical、Lunan Pharmaceuticalなどが含まれています。世界のエピルビシン塩酸塩注射液市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、エピルビシン塩酸塩注射液市場規模を推定する際に考慮しました。

・エピルビシン塩酸塩注射液市場の概要
- 製品の定義
- エピルビシン塩酸塩注射液のタイプ別セグメント
- 世界のエピルビシン塩酸塩注射液市場規模：タイプ別分析（5mg、10mg）
- エピルビシン塩酸塩注射液の用途別セグメント
- 世界のエピルビシン塩酸塩注射液市場規模：用途別分析（白血病、悪性リンパ腫、多発性骨髄腫、乳がん、肺がん、軟部肉腫、胃がん、大腸がん、卵巣がん、その他）
- 世界のエピルビシン塩酸塩注射液市場規模予測（2018年-2029年）
- エピルビシン塩酸塩注射液の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- エピルビシン塩酸塩注射液市場の競争状況およびトレンド

・エピルビシン塩酸塩注射液の地域別市場規模
- 北米のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- アメリカのエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- ヨーロッパのエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- アジア太平洋のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- 中国のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- 日本のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- 韓国のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- インドのエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- オーストラリアのエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- 中南米のエピルビシン塩酸塩注射液市場規模（2018年-2029年）
- 中東・アフリカのエピルビシン塩酸塩注射液市場規模（2018年-2029年）

・タイプ別セグメント：5mg、10mg
- 世界のエピルビシン塩酸塩注射液のタイプ別販売量（2018年-2023年）
- 世界のエピルビシン塩酸塩注射液のタイプ別売上（2018年-2023年）
- 世界のエピルビシン塩酸塩注射液のタイプ別価格

・用途別セグメント：白血病、悪性リンパ腫、多発性骨髄腫、乳がん、肺がん、軟部肉腫、胃がん、大腸がん、卵巣がん、その他
- 世界のエピルビシン塩酸塩注射液の用途別販売量（2018年-2023年）
- 世界のエピルビシン塩酸塩注射液の用途別売上（2018年-2023年）
- 世界のエピルビシン塩酸塩注射液の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Akorn、Aurobindo Pharma、Cipla、Ebewe Pharma、Fresenius Kabi Usa、Impax Laboratories、Mylan Laboratories、Nippon Kayaku、Pfizer、Sawai Pharmaceutical、Zennova、Beijing Union Pharmaceutical Factory、Hisun Pharmaceutical、Hanhui Pharmaceutical、Lunan Pharmaceutical

・産業チェーンと販売チャネルの分析
- エピルビシン塩酸塩注射液産業チェーン分析
- エピルビシン塩酸塩注射液の主要原材料
- エピルビシン塩酸塩注射液の販売チャネル
- エピルビシン塩酸塩注射液のディストリビューター
- エピルビシン塩酸塩注射液の主要顧客

・エピルビシン塩酸塩注射液市場ダイナミクス
- エピルビシン塩酸塩注射液の業界動向
- エピルビシン塩酸塩注射液市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Epirubicin Hydrochloride Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Epirubicin Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Epirubicin Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Epirubicin Hydrochloride Injection include Akorn, Aurobindo Pharma, Cipla, Ebewe Pharma, Fresenius Kabi Usa, Impax Laboratories, Mylan Laboratories, Nippon Kayaku and Pfizer, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Epirubicin Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epirubicin Hydrochloride Injection.
The Epirubicin Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Epirubicin Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epirubicin Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Akorn
Aurobindo Pharma
Cipla
Ebewe Pharma
Fresenius Kabi Usa
Impax Laboratories
Mylan Laboratories
Nippon Kayaku
Pfizer
Sawai Pharmaceutical
Zennova
Beijing Union Pharmaceutical Factory
Hisun Pharmaceutical
Hanhui Pharmaceutical
Lunan Pharmaceutical
Segment by Type
5mg
10mg
Segment by Application
Leukemia
Malignant Lymphoma
Multiple Myeloma
Breast Cancer
Lung Cancer
Soft Tissue Sarcoma
Stomach Cancer
Colorectal Cancer
Ovarian Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epirubicin Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epirubicin Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Epirubicin Hydrochloride Injection Market Overview
1.1 Product Overview and Scope of Epirubicin Hydrochloride Injection
1.2 Epirubicin Hydrochloride Injection Segment by Type
1.2.1 Global Epirubicin Hydrochloride Injection Market Value Comparison by Type (2023-2029)
1.2.2 5mg
1.2.3 10mg
1.3 Epirubicin Hydrochloride Injection Segment by Application
1.3.1 Global Epirubicin Hydrochloride Injection Market Value by Application: (2023-2029)
1.3.2 Leukemia
1.3.3 Malignant Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Lung Cancer
1.3.7 Soft Tissue Sarcoma
1.3.8 Stomach Cancer
1.3.9 Colorectal Cancer
1.3.10 Ovarian Cancer
1.3.11 Others
1.4 Global Epirubicin Hydrochloride Injection Market Size Estimates and Forecasts
1.4.1 Global Epirubicin Hydrochloride Injection Revenue 2018-2029
1.4.2 Global Epirubicin Hydrochloride Injection Sales 2018-2029
1.4.3 Global Epirubicin Hydrochloride Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Epirubicin Hydrochloride Injection Market Competition by Manufacturers
2.1 Global Epirubicin Hydrochloride Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Epirubicin Hydrochloride Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Epirubicin Hydrochloride Injection Average Price by Manufacturers (2018-2023)
2.4 Global Epirubicin Hydrochloride Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Epirubicin Hydrochloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Epirubicin Hydrochloride Injection, Product Type & Application
2.7 Epirubicin Hydrochloride Injection Market Competitive Situation and Trends
2.7.1 Epirubicin Hydrochloride Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Epirubicin Hydrochloride Injection Players Market Share by Revenue
2.7.3 Global Epirubicin Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Epirubicin Hydrochloride Injection Retrospective Market Scenario by Region
3.1 Global Epirubicin Hydrochloride Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Epirubicin Hydrochloride Injection Global Epirubicin Hydrochloride Injection Sales by Region: 2018-2029
3.2.1 Global Epirubicin Hydrochloride Injection Sales by Region: 2018-2023
3.2.2 Global Epirubicin Hydrochloride Injection Sales by Region: 2024-2029
3.3 Global Epirubicin Hydrochloride Injection Global Epirubicin Hydrochloride Injection Revenue by Region: 2018-2029
3.3.1 Global Epirubicin Hydrochloride Injection Revenue by Region: 2018-2023
3.3.2 Global Epirubicin Hydrochloride Injection Revenue by Region: 2024-2029
3.4 North America Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.4.1 North America Epirubicin Hydrochloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Epirubicin Hydrochloride Injection Sales by Country (2018-2029)
3.4.3 North America Epirubicin Hydrochloride Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.5.1 Europe Epirubicin Hydrochloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Epirubicin Hydrochloride Injection Sales by Country (2018-2029)
3.5.3 Europe Epirubicin Hydrochloride Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Epirubicin Hydrochloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Epirubicin Hydrochloride Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Epirubicin Hydrochloride Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.7.1 Latin America Epirubicin Hydrochloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Epirubicin Hydrochloride Injection Sales by Country (2018-2029)
3.7.3 Latin America Epirubicin Hydrochloride Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Epirubicin Hydrochloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Epirubicin Hydrochloride Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Epirubicin Hydrochloride Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Epirubicin Hydrochloride Injection Sales by Type (2018-2029)
4.1.1 Global Epirubicin Hydrochloride Injection Sales by Type (2018-2023)
4.1.2 Global Epirubicin Hydrochloride Injection Sales by Type (2024-2029)
4.1.3 Global Epirubicin Hydrochloride Injection Sales Market Share by Type (2018-2029)
4.2 Global Epirubicin Hydrochloride Injection Revenue by Type (2018-2029)
4.2.1 Global Epirubicin Hydrochloride Injection Revenue by Type (2018-2023)
4.2.2 Global Epirubicin Hydrochloride Injection Revenue by Type (2024-2029)
4.2.3 Global Epirubicin Hydrochloride Injection Revenue Market Share by Type (2018-2029)
4.3 Global Epirubicin Hydrochloride Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Epirubicin Hydrochloride Injection Sales by Application (2018-2029)
5.1.1 Global Epirubicin Hydrochloride Injection Sales by Application (2018-2023)
5.1.2 Global Epirubicin Hydrochloride Injection Sales by Application (2024-2029)
5.1.3 Global Epirubicin Hydrochloride Injection Sales Market Share by Application (2018-2029)
5.2 Global Epirubicin Hydrochloride Injection Revenue by Application (2018-2029)
5.2.1 Global Epirubicin Hydrochloride Injection Revenue by Application (2018-2023)
5.2.2 Global Epirubicin Hydrochloride Injection Revenue by Application (2024-2029)
5.2.3 Global Epirubicin Hydrochloride Injection Revenue Market Share by Application (2018-2029)
5.3 Global Epirubicin Hydrochloride Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Akorn
6.1.1 Akorn Corporation Information
6.1.2 Akorn Description and Business Overview
6.1.3 Akorn Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Akorn Epirubicin Hydrochloride Injection Product Portfolio
6.1.5 Akorn Recent Developments/Updates
6.2 Aurobindo Pharma
6.2.1 Aurobindo Pharma Corporation Information
6.2.2 Aurobindo Pharma Description and Business Overview
6.2.3 Aurobindo Pharma Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Aurobindo Pharma Epirubicin Hydrochloride Injection Product Portfolio
6.2.5 Aurobindo Pharma Recent Developments/Updates
6.3 Cipla
6.3.1 Cipla Corporation Information
6.3.2 Cipla Description and Business Overview
6.3.3 Cipla Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cipla Epirubicin Hydrochloride Injection Product Portfolio
6.3.5 Cipla Recent Developments/Updates
6.4 Ebewe Pharma
6.4.1 Ebewe Pharma Corporation Information
6.4.2 Ebewe Pharma Description and Business Overview
6.4.3 Ebewe Pharma Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ebewe Pharma Epirubicin Hydrochloride Injection Product Portfolio
6.4.5 Ebewe Pharma Recent Developments/Updates
6.5 Fresenius Kabi Usa
6.5.1 Fresenius Kabi Usa Corporation Information
6.5.2 Fresenius Kabi Usa Description and Business Overview
6.5.3 Fresenius Kabi Usa Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Fresenius Kabi Usa Epirubicin Hydrochloride Injection Product Portfolio
6.5.5 Fresenius Kabi Usa Recent Developments/Updates
6.6 Impax Laboratories
6.6.1 Impax Laboratories Corporation Information
6.6.2 Impax Laboratories Description and Business Overview
6.6.3 Impax Laboratories Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Impax Laboratories Epirubicin Hydrochloride Injection Product Portfolio
6.6.5 Impax Laboratories Recent Developments/Updates
6.7 Mylan Laboratories
6.6.1 Mylan Laboratories Corporation Information
6.6.2 Mylan Laboratories Description and Business Overview
6.6.3 Mylan Laboratories Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mylan Laboratories Epirubicin Hydrochloride Injection Product Portfolio
6.7.5 Mylan Laboratories Recent Developments/Updates
6.8 Nippon Kayaku
6.8.1 Nippon Kayaku Corporation Information
6.8.2 Nippon Kayaku Description and Business Overview
6.8.3 Nippon Kayaku Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Nippon Kayaku Epirubicin Hydrochloride Injection Product Portfolio
6.8.5 Nippon Kayaku Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pfizer Epirubicin Hydrochloride Injection Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Sawai Pharmaceutical
6.10.1 Sawai Pharmaceutical Corporation Information
6.10.2 Sawai Pharmaceutical Description and Business Overview
6.10.3 Sawai Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sawai Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.10.5 Sawai Pharmaceutical Recent Developments/Updates
6.11 Zennova
6.11.1 Zennova Corporation Information
6.11.2 Zennova Epirubicin Hydrochloride Injection Description and Business Overview
6.11.3 Zennova Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zennova Epirubicin Hydrochloride Injection Product Portfolio
6.11.5 Zennova Recent Developments/Updates
6.12 Beijing Union Pharmaceutical Factory
6.12.1 Beijing Union Pharmaceutical Factory Corporation Information
6.12.2 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Description and Business Overview
6.12.3 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Product Portfolio
6.12.5 Beijing Union Pharmaceutical Factory Recent Developments/Updates
6.13 Hisun Pharmaceutical
6.13.1 Hisun Pharmaceutical Corporation Information
6.13.2 Hisun Pharmaceutical Epirubicin Hydrochloride Injection Description and Business Overview
6.13.3 Hisun Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Hisun Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.13.5 Hisun Pharmaceutical Recent Developments/Updates
6.14 Hanhui Pharmaceutical
6.14.1 Hanhui Pharmaceutical Corporation Information
6.14.2 Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Description and Business Overview
6.14.3 Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.14.5 Hanhui Pharmaceutical Recent Developments/Updates
6.15 Lunan Pharmaceutical
6.15.1 Lunan Pharmaceutical Corporation Information
6.15.2 Lunan Pharmaceutical Epirubicin Hydrochloride Injection Description and Business Overview
6.15.3 Lunan Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Lunan Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.15.5 Lunan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Epirubicin Hydrochloride Injection Industry Chain Analysis
7.2 Epirubicin Hydrochloride Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Epirubicin Hydrochloride Injection Production Mode & Process
7.4 Epirubicin Hydrochloride Injection Sales and Marketing
7.4.1 Epirubicin Hydrochloride Injection Sales Channels
7.4.2 Epirubicin Hydrochloride Injection Distributors
7.5 Epirubicin Hydrochloride Injection Customers
8 Epirubicin Hydrochloride Injection Market Dynamics
8.1 Epirubicin Hydrochloride Injection Industry Trends
8.2 Epirubicin Hydrochloride Injection Market Drivers
8.3 Epirubicin Hydrochloride Injection Market Challenges
8.4 Epirubicin Hydrochloride Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ エピルビシン塩酸塩注射液のグローバル市場2023年：5mg、10mg(Global Epirubicin Hydrochloride Injection Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ナルメフェン塩酸塩注射液のグローバル市場予測2023-2029
  • アンブロキソール塩酸塩塩化ナトリウム注射液のグローバル市場予測2023-2029
  • 注射用塩酸クリンダマイシンのグローバル市場2023年：筋肉注射、点滴
  • オメプラゾール腸溶性カプセルのグローバル市場2023年：10mg/本、20mg/本
  • 世界のベクロニウム臭化物注射市場2022年：10mg /バイアル、20mg/バイアル